These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3217429)

  • 21. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP; Heath I; Hendrix JC; Shannon HE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release.
    Marcos B; Gil-Bea FJ; Hirst WD; García-Alloza M; Ramírez MJ
    Eur J Neurosci; 2006 Sep; 24(5):1299-306. PubMed ID: 16987217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the interactions of gallamine with muscarinic receptors from brain.
    Ellis J; Lenox RH
    Biochem Pharmacol; 1985 Jun; 34(12):2214-7. PubMed ID: 4004942
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of pyritinol on the dopaminergic system and behavioural outcome in an animal model of mild chronic postnatal hypoxia.
    Lun A; Gruetzmann H; Wustmann C; Szuesz L; Dominick B; Horvath G; Fischer HD; Nagy I; Gross J
    Biomed Biochim Acta; 1989; 48(2-3):S237-42. PubMed ID: 2730616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some effects of CNS cholinergic neurons on memory.
    Goto T; Kuzuya F; Endo H; Tajima T; Ikari H
    J Neural Transm Suppl; 1990; 30():1-11. PubMed ID: 2391512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the mechanism of action of Encephabol.
    Martin KJ
    J Int Med Res; 1983; 11(2):55-65. PubMed ID: 6189751
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental research on the effect of piracetam and pyritinol on the central nervous system].
    Stroesco V; Gane P; Granici A; Constantinidi M
    Physiologie; 1977; 14(3):165-72. PubMed ID: 411142
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of pyritinol on the distribution of electrical brain activity.
    Ihl R; Maurer K; Dierks T; Wannemacher W
    Pharmacopsychiatry; 1988 Nov; 21(6):343-5. PubMed ID: 3244765
    [No Abstract]   [Full Text] [Related]  

  • 29. Alcohol, pancreatic muscarinic receptors and acute pancreatitis.
    Grönroos JM; Kaila T; Hietaranta AJ
    Exp Toxicol Pathol; 1994 Apr; 45(8):503-5. PubMed ID: 8054828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tay-Sachs disease, Alzheimer's disease and the cholinergic hypothesis.
    Tucker L
    S Afr Med J; 1986 Dec; 70(13):847. PubMed ID: 3798280
    [No Abstract]   [Full Text] [Related]  

  • 31. Protection of cell proteins against free-radical attack by nootropic drugs: scavenger effect of pyritinol confirmed by electron spin resonance spectroscopy.
    Pavlík A; Pilar J
    Neuropharmacology; 1989 Jun; 28(6):557-61. PubMed ID: 2547179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of pyritinol upon P300 topography.
    Maurer K; Dierks T; Ihl R
    Psychiatry Res; 1989 Sep; 29(3):413-5. PubMed ID: 2692058
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of subchronic administration of pyritinol on receptor deficits and phosphatidylinositol metabolism in the brain of the aged mouse.
    Hartmann H; Cohen SA; Müller WE
    Neuropharmacology; 1993 Feb; 32(2):119-25. PubMed ID: 8450941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of KW-6055, a novel benzylpyridine derivative, on central cholinergic systems].
    Kurokawa M; Mori A; Shiozaki S; Kanda T; Yoshizaki R; Ishii A
    Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):435-43. PubMed ID: 1398340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyritinol hydrochloride (encephabol) and senile dementia.
    Flood MK
    Br Med J; 1979 Apr; 1(6171):1148. PubMed ID: 376047
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical effect of Encephabol (pyritinol) in the treatment of cerebrovascular disorders.
    Tazaki Y; Omae T; Kuromaru S; Ohtomo E; Hasegawa K; Mori A; Kurihara M; Kutsusawa N; Okada T
    J Int Med Res; 1980; 8(2):118-26. PubMed ID: 6989681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of the administration of pyritinol on the clinical course of traumatic coma.
    Dalle Ore G; Bricolo A; Alexandre A
    J Neurosurg Sci; 1980; 24(1):1-8. PubMed ID: 7381550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of scopolamine on local glucose metabolism in rat brain.
    Weinberger J; Greenberg JH; Waldman MT; Sylvestro A; Reivich M
    Brain Res; 1979 Nov; 177(2):337-45. PubMed ID: 497835
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of various cerebral metabolic activators on glucose metabolism of brain.
    Watanabe S; Kono S; Nakashima Y; Mitsunobu K; Otsuki S
    Folia Psychiatr Neurol Jpn; 1975; 29(1):67-76. PubMed ID: 1098982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of pyrithioxine in a group of visually handicapped children. A preliminary report from the School for the Blind, Worcester.
    Brand HJ
    S Afr Med J; 1975 May; 49(19):769-73. PubMed ID: 1094565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.